Jefferies analyst Raj Denhoy boosted his price target on DexCom (NASDAQ: DXCM) from $21 to $27 following a strong Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE